Pan-Cancer Analysis of the Oncogenic and Prognostic Role of PKM2: A Potential Target for Survival and Immunotherapy

Figure 3

Epigenetic variants of PKM in different cancers of TCGA. (a) The alteration frequency and the mutation type. (b) The mutation site. (c) The 3D structure of PKM2. (d) The different methylation regions associated with PKM2 in UCEC. (e) The partial positive results of PKM2 promoter methylation levels in multiple tumors. (f) The expression level of PKM2 phosphoprotein (XP_006720633.1, S111, S201, Y222, S323, S436, and S511) in clear cell RCC. (e) The expression level of PKM2 phosphoprotein (NP_006720633, S111, S276, and S323) in UCEC.